N-(4-(N-(5-Methylisoxazol-3-yl)sulfamoyl)phenyl)acetamide, 95.0%, 5g

4,4'-Bis((E)-2-(9-ethyl-9H-carbazol-3-yl)vinyl)-1,1'-biphenyl, 95% mix TBC as stabilizer, 1g

2-(1H-Benzoimidazol-2-yl)ethylamine dihydrochloride, 95.0%, 5g

6-ethyl-3-(prop-2-yn-1-yl)benzo[d]thiazol-2(3H)-imine hydrobromide, 95.0%, 500mg

1,2,3,4-Tetrahydro-quinoline-7-carboxylic acid, 98%, 250mg

4-Chloro-2-trifluoromethylpyridine, 97.0%, 1g

4-(Difluoromethyl)benzoic acid, 99.0%, 5g

Nanopolvo de óxido de tungsteno (VI) 99+% APS 30-70 nm 25 g

6-bromo-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95%, 250mg

3-Hydroxybenzisoxazole, 98.0%, 10g

7-Bromo-5-nitro-1H-indazole, 95.0%, 25g

4-Bromo-3-chloro-2-methylaniline, 95.0%, 25g

Tris(1,3-dichloro-2-propyl) Phosphate>90.0%(GC)500g